DelveInsight's "Congenital Adrenal Hyperplasia Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 8+ pipeline drugs in the Congenital Adrenal Hyperplasia pipeline ...
People with classic congenital adrenal hyperplasia (CAH) may suffer from impaired bone health, largely due to standard treatments. Most often caused by a genetic mutation in the 21-hydroxylase enzyme, ...
Patients with primary adrenal insufficiency had a higher risk for all-cause mortality than the general population or control individuals without the condition, with cardiovascular disease being a ...
Androgen receptor (AR) signaling has a key role in the pathogenesis of prostate cancer. AR gene amplification, AR overexpression, and activating mutations in the AR occur more frequently as castration ...
Performance in endurance sports, such as long-distance running, cycling, and cross-country skiing, requires sustained activity over prolonged periods of time, and is influenced by multiple factors, ...
The first CRFR1 antagonist (crinecerfont) to be used for the treatment of congenital adrenal hyperplasia recently received FDA approval. This Clinical Outlook discusses the latest phase III studies in ...